Earlier this year, the Centers for Medicare and Medicaid Services (CMS) announced that it was forming an interagency group to review potential changes to the federal Stark (or physician self-referral) Law. The federal Stark Law generally prohibits a physician from referring certain designated health services to an entity with which the physician, (or an immediate family member of the physician), has a financial relationship.
Topics: Licensure and Discipline
Scott R. Grubman, Esq. Gregory A. Tanner, Esq. Chilivis, Cochran, Larkins & Bever, LLP
On June 7, 2017, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS) released a report estimating that Medicare paid over $729 million in improper EHR incentive payments to healthcare providers who did not meet meaningful use requirements.
Scott R. Grubman, Esq.
Gregory A. Tanner, Esq.
Chilivis, Cochran, Larkins & Bever, LLP
In response to the nationwide opioid epidemic, the U.S. Department of Justice (DOJ) has announced the creation of the Opioid Fraud and Abuse Detection Unit.
Written by, Scott R. Grubman, Esq., Gregory A. Tanner, Esq., Chilivis, Cochran, Larkins & Bever, LLP
On May 31, 2017, the U.S. Department of Justice (DOJ) announced that eClinicalWorks (ECW), one of the nation’s largest vendors of electronic health records (EHR) software, along with certain individual employees, has agreed to pay $155 million to settle allegations that ECW violated the federal False Claims Act (FCA).
On March 6, 2017, the U.S. Department of Health and Human Services’ Office of Inspector General (OIG) published data regarding the enforcement activities of Medicaid Fraud Control Units (MFCUs) across the country during fiscal year 2016.
Recent enforcement actions by the US Food and Drug Administration (FDA) and the US Department of Justice (DOJ) highlight ongoing government scrutiny regarding the sources of prescription drugs and medical devices dispensed by healthcare providers. Importantly, this scrutiny is not limited to distributors: federal regulators have pursued criminal and civil actions against physicians and physician practices that receive drugs and devices from unauthorized sources. Accordingly, healthcare providers should take proactive steps to avoid obtaining drugs and devices from unauthorized sources, particularly foreign entities (e.g., online retail pharmacies based in foreign countries).